SU-5408
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 407899

CAS#: 15966-93-5

Description: SU-5408, also known as VEGFR2 Kinase Inhibitor I, is a potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC50 = 70 nM).


Price and Availability

Size
Price

100mg
USD 650
1g
USD 2850
Size
Price

200mg
USD 950
2g
USD 4250
Size
Price

500mg
USD 1650
5g
USD 6950

SU-5408, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 407899
Name: SU-5408
CAS#: 15966-93-5
Chemical Formula: C18H18N2O3
Exact Mass: 310.1317
Molecular Weight: 310.353
Elemental Analysis: C, 69.66; H, 5.85; N, 9.03; O, 15.47


Synonym: SU-5408; SU 5408; SU5408; VEGFR2 Kinase Inhibitor I

IUPAC/Chemical Name: 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, ethyl ester

InChi Key: PMUJUSJUVIXDQC-LCYFTJDESA-N

InChi Code: InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9-

SMILES Code: O=C(C1=C(C)NC(/C=C2C(NC3=C\2C=CC=C3)=O)=C1C)OCC


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1. Sun, L.,Tran, N.,Tang, F., et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. Journal of Medicinal Chemistry 41(14), 2588-2603 (1998).